A systematic review and meta-analysis involving 138,001 patients compared same-day discharge (SDD) laparoscopic sleeve gastrectomy (LSG) with inpatient (IP) procedures. Findings revealed SDD resulted in significantly fewer emergency room visits versus IP (odds ratio 1.52). No significant differences were found in readmission (odds ratio 1.48) or reoperation rates (odds ratio 0.62). Overall, SDD LSG demonstrated […]
Category: Metabolic and Bariatric Surgery
Concomitant surgery improves gastroesophageal reflux outcomes in obesity
A propensity score-matched analysis of 406 patients revealed that concomitant laparoscopic sleeve gastrectomy (LSG) with hiatal hernia repair (HHR) significantly improves outcomes for gastroesophageal reflux disease (GERD) compared to LSG alone. While operative time was longer with HHR, the only notable difference in complications was a reduced incidence of new GERD symptoms in patients receiving […]
Bariatric surgery enhances survival and is cost-effective for cirrhosis patients.
Bariatric surgery significantly improves survival outcomes among patients with obesity and cirrhosis, showing observed survival of 9.09 years compared to 8.23 years for lifestyle interventions. The incremental cost-effectiveness ratios were $18,679 for sleeve gastrectomy and $44,704 for gastric bypass in cirrhosis cohorts, proving cost-effective when compared to a $100,000 willingness-to-pay threshold for quality-adjusted life years. […]
Serious complications significantly impact surgeons’ mental health.
The study reveals that 41.3% of metabolic and bariatric surgeons experience diminished professional confidence due to serious complications, with 39.7% affected at home. Feelings of guilt, anxiety, and sleep disorders were reported by 53.7%, 53.7%, and 44.6% of respondents, respectively. Key barriers to seeking help include excessive workload, a macho culture, and poor communication. Notably, […]
Standardized approach established for Endoscopic Sleeve Gastroplasty
A global expert consensus defined standardized practices for Endoscopic Sleeve Gastroplasty (ESG) utilizing a modified Delphi method. Six experts, after three survey rounds, achieved 100% agreement on six cognitive skill statements and high consensus on 21 technical skill statements. Key procedural elements emphasized were starting at the incisura, using at least six sutures, and avoiding […]
New obesity treatments show promise in addressing weight loss challenges
Recent advancements in obesity treatment highlight new pipeline agents that effectively match weight loss results of surgery. Notably, GLP-1 analogs not only reduce weight but also improve obesity-related health issues. However, significant gaps remain, with alternative treatment options needed to address muscle mass loss and energy expenditure decline. Developing novel therapies, including myostatin inhibitors and […]
Liver transplant with sleeve gastrectomy sustains weight loss and reduces obesity-related complications
The study demonstrates that simultaneous liver transplant and sleeve gastrectomy leads to significant long-term weight loss, improved diabetes and hypertension outcomes, and lower rates of allograft steatosis compared to liver transplant alone. Over a follow-up period, ltsg patients, starting with a higher average BMI, showed remarkable post-operative results, including a decrease in diabetes prevalence and […]
Roux-en-Y Gastric Bypass Outperforms Sleeve Gastrectomy in Long-Term Outcomes
After a decade of follow-up in the SM-BOSS trial, Roux-en-Y gastric bypass (RYGB) demonstrated superior efficacy in achieving percentage excess body mass index loss compared to sleeve gastrectomy (SG), with means of 65.9% and 56.1% respectively. Though total weight loss showed no significant difference, patients undergoing SG faced higher conversion rates due to inadequate weight […]
Metabolic and bariatric surgery reduces cardiovascular risks in obesity.
A comparative analysis of metabolic and bariatric surgery (MBS) versus glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy indicated that MBS significantly lowers the hazard of cardiovascular disease in patients with obesity. Specifically, MBS demonstrated a reduced risk for the primary composite outcome of cardiovascular disease (HR 0.54) and secondary outcomes including heart failure (HR 0.45), […]
GLP-1 Receptor Agonists Show Weight Loss Benefits Post Bariatric Surgery
A systematic review and meta-analysis of 19 studies involving 1,290 patients revealed that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) effectively address suboptimal initial clinical response and weight gain recurrence after bariatric surgery. Notable results included pooled total weight loss percentages of 9.24% for liraglutide, 11.38% for semaglutide, and 15.50% for tirzepatide after three months, alongside […]